As a focus on longevity sharpens, biomarkers are entering the conversation as a health solution for the present day and the ...

Research by the Barcelona Institute for Biomedical Research (IIBB), part of the Spanish National Research Council (CSIC), and ...

Digestive system cancers, including hepatobiliary and gastrointestinal malignancies, remain a major global oncological burden ...

The rarity of sarcoma complicates clinical trial design and biomarker-driven treatment, explains Alexander Spira, MD, PhD, ...

Middle-aged adults with positive plasma biomarkers for Alzheimer disease show accelerated decline in specific cognitive domains.

Cognitive decline in very old adults has been considered for decades to be an almost inevitable consequence of aging. In ...

Learn why comprehensive biomarker testing is essential before starting any lung cancer treatment. Hear from patients and ...

Cognitive decline in very old adults has been considered for decades to be an almost inevitable consequence of aging.

Researchers have developed a chip-based metasurface biosensor that can detect traumatic brain injury (TBI) biomarkers at ...

PrimeC is now FDA-cleared to enter Phase III development in ALS, as competition in the indication intensifies with several ...

Biomarker testing in colorectal cancer (CRC) informs doctors about unique features of cancer that may influence its growth, spread, recurrence, and treatment response. Colorectal cancer (CRC), which ...

Researchers from the EHU-University of the Basque Country have developed a robust protocol to detect the molecules involved ...